M. Ziller

730 total citations
26 papers, 586 citations indexed

About

M. Ziller is a scholar working on Oncology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. Ziller has authored 26 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Genetics and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. Ziller's work include Bone health and treatments (14 papers), Estrogen and related hormone effects (9 papers) and Reproductive Health and Contraception (5 papers). M. Ziller is often cited by papers focused on Bone health and treatments (14 papers), Estrogen and related hormone effects (9 papers) and Reproductive Health and Contraception (5 papers). M. Ziller collaborates with scholars based in Germany, France and United Kingdom. M. Ziller's co-authors include Peyman Hadji, Matthias Kalder, Volker Ziller, Ute‐Susann Albert, Uwe Wagner, Annette Hasenburg, Joachim Kuck, D. G. Kieback, Karel Kostev and W. Dornoff and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

M. Ziller

26 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ziller Germany 12 317 182 166 115 83 26 586
Lindsay Carlsson Canada 9 324 1.0× 288 1.6× 49 0.3× 10 0.1× 29 0.3× 25 667
Aviva G. Asnis-Alibozek United States 5 170 0.5× 150 0.8× 6 0.0× 158 1.4× 69 0.8× 7 489
A.M. Thompson United Kingdom 11 223 0.7× 78 0.4× 3 0.0× 136 1.2× 51 0.6× 24 552
Michelle B. Nadler Canada 12 378 1.2× 34 0.2× 28 0.2× 3 0.0× 138 1.7× 48 651
K. Pritchard Canada 10 216 0.7× 85 0.5× 7 0.0× 7 0.1× 25 0.3× 22 444
PA Ganz United States 8 579 1.8× 74 0.4× 13 0.1× 3 0.0× 81 1.0× 26 824
Kathryn Bylow United States 14 367 1.2× 35 0.2× 47 0.3× 2 0.0× 23 0.3× 38 890
Kathryn Monson United Kingdom 10 238 0.8× 68 0.4× 6 0.0× 6 0.1× 15 0.2× 15 519
Yoland Antill Australia 16 384 1.2× 125 0.7× 24 0.1× 79 1.0× 46 800
Leena Vehmanen Finland 16 865 2.7× 128 0.7× 283 1.7× 102 1.2× 34 1.0k

Countries citing papers authored by M. Ziller

Since Specialization
Citations

This map shows the geographic impact of M. Ziller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ziller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ziller more than expected).

Fields of papers citing papers by M. Ziller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ziller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ziller. The network helps show where M. Ziller may publish in the future.

Co-authorship network of co-authors of M. Ziller

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ziller. A scholar is included among the top collaborators of M. Ziller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ziller. M. Ziller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hadji, Peyman, M. Ziller, Katrin Birkholz, et al.. (2014). Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study. Breast Cancer Research and Treatment. 144(2). 343–351. 12 indexed citations
3.
Ziller, Volker, et al.. (2013). Prevalence of female subfertility in German gynecological practices. Gynecological Endocrinology. 29(8). 767–770. 6 indexed citations
4.
Ziller, M., et al.. (2013). Risk of venous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis. Archives of Gynecology and Obstetrics. 289(2). 413–419. 15 indexed citations
5.
Ziller, M., Asia N Rashed, Volker Ziller, & Karel Kostev. (2013). The Prescribing of Contraceptives for Adolescents in German Gynecologic Practices in 2007 and 2011: A Retrospective Database Analysis. Journal of Pediatric and Adolescent Gynecology. 26(5). 261–264. 8 indexed citations
7.
Ziller, M., et al.. (2012). Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal women. Gynecological Endocrinology. 28(12). 1002–1005. 4 indexed citations
8.
Hadji, Peyman, M. Ziller, Tobias Maurer, et al.. (2012). The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer. Journal of bone oncology. 1(3). 88–94. 2 indexed citations
10.
Kalder, Matthias, Umberto Albert, Katrin Birkholz, et al.. (2011). P2-19-03: Influence of Zoledronic Acid on BMD in Premenopausal Women with Breast Cancer and Neoadjuvant or Adjuvant Chemotherapy and/or Endocrine Treatment – The ProBone Studies.. Cancer Research. 71(24_Supplement). P2–19. 1 indexed citations
12.
Hadji, Peyman, Lina Asmar, Johanna G. H. van Nes, et al.. (2010). The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies. Journal of Cancer Research and Clinical Oncology. 137(6). 1015–1025. 32 indexed citations
13.
Hadji, Peyman, M. Ziller, Ute‐Susann Albert, & Matthias Kalder. (2010). Assessment of fracture risk in women with breast cancer using current vs emerging guidelines. British Journal of Cancer. 102(4). 645–650. 21 indexed citations
15.
Ziller, Volker, Matthias Kalder, Ute‐Susann Albert, et al.. (2009). Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Annals of Oncology. 20(3). 431–436. 220 indexed citations
16.
Hadji, Peyman, et al.. (2009). The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. European Journal of Cancer. 45(18). 3205–3212. 65 indexed citations
17.
18.
Hadji, Peyman, M. Ziller, D. G. Kieback, et al.. (2009). The effect of exemestane or tamoxifen on markers of bone turnover: Results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial. The Breast. 18(3). 159–164. 42 indexed citations
19.
Ziller, M., et al.. (2008). Bone effects of exemestane versus tamoxifen within the TEAM Trial: Results of a prospective randomized bone substudy. Journal of Clinical Oncology. 26(15_suppl). 572–572. 1 indexed citations
20.
Ziller, M., et al.. (2007). Compliance with Tamoxifen and Arimidex in the adjuvant treatment of women with breast cancer. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 4(2). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026